Categories: Technology

PROACTIS SA – Press Release (nomination C. Carter and P. Shepherd) 19.12.2025

Press Release

Evolution of PROACTIS SA Governance

PARIS, France – (19 December 2025) — Under the terms of the Board of Directors of the company PROACTIS SA (ISIN code: FR0004052561) held on the 18th of December 2025, Mrs. Charlotte CARTER has been appointed as Director in replacement of Mrs. Bonnie MITCHELL, resigning.

Charlotte Carter joined Proactis in 2013. She is Vice President for Product at Proactis, where she leads a high-performing team dedicated to investing in our next generation of software products. She brings over 12 years of experience in the Source-to-Pay software domain, with expertise in procurement, spend control and SaaS and is supported by CIPS certification and executive education from MIT Sloan.

During this same meeting, Mr. Peter SHEPHERD has been appointed as Director in replacement of Mr. Graham DAVIS, resigning.

Peter Shepherd joined Proactis in November 2025 after being CFO at Medical Management Systems LTD. He brings over 20 years of experience in senior financial roles, with strong expertise in strategy, growth management, and financial excellence within international organizations. His experience and leadership will be instrumental in helping Proactis Group continue its evolution.

Shareholders will be asked to approve these appointments at the next Annual General Meeting called to approve the financial statements for the year ended January 31st, 2026.

As a result of these changes, the Board of Directors of PROACTIS SA is now composed as follows:

Member Functions Mandate expiry date
Andrew REARDON Chairman of the Board of Directors
Chief Executive Officer
Annual General Meeting to approve the financial statements for the year ending January 31, 2028
Charlotte CARTER Director Annual General Meeting to approve the financial statements for the year ending January 31, 2030
Peter SHEPHERD Director Annual General Meeting to approve the financial statements for the year ending January 31, 2028
Maria LARSEN Director Annual General Meeting to approve the financial statements for the year ending January 31, 2028

* * * *

Contacts
Tel: +33 (0)1 53 25 55 00
E-mail: investorContact@proactis.com

* * * *

GlobeNews Wire

Recent Posts

NYSE Content Update: Starfighters Space Celebrates NYSE American Listing

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 20, 2026…

2 hours ago

Chandigarh University Launches 3-Month ‘SANDBOX Residential Program’ During AI Fest 2026; To Boost Startup Ecosystem in North India

'AI Fest-2026': Chandigarh University Launches 'Centre of Excellence in Digital Marketing' With 'Earn While Learn'…

2 hours ago

Perfios Launches ‘KScan AI’: Empowers BFSI with AI-powered Business Intelligence and Risk Assessment of 30 Million Indian MSMEs

BENGALURU, India, Feb. 20, 2026 /PRNewswire/ -- Perfios.ai, India's leading B2B SaaS TechFin, today announced…

2 hours ago

Coca-Cola India Brings Back Rimzim Jeera with a New Campaign that Refuses to be Subtle

NEW DELHI, Feb. 20, 2026 /PRNewswire/ -- India rediscovers its love for local flavours, Coca-Cola…

2 hours ago

PartnerOne Continues Investment in AI with XYPRO Applied AI Technology

RIVERSIDE, Calif., Feb. 19, 2026 /PRNewswire/ -- XYPRO, a PartnerOne company and market leader of…

2 hours ago

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical…

5 hours ago